Pharmacological treatment for insomnia in patients with major depressive disorder

References

• Taylor SS, Hughes JM, Coffman CJ, et al. Prevalence of and characteristics associated with insomnia and obstructive sleep apnea among veterans with knee and hip osteoarthritis. BMC Musculoskelet Disord. 2018 Mar 9;19(1):79.
   PubMed Web of Science ®Google Scholar
• Jordan P, Shedden-Mora MC, Löwe B. Predicting suicidal ideation in primary care: an approach to identify easily assessable key variables. Gen Hosp Psychiatry. 2018;51:106–111. Mar,Apr.
   PubMed Web of Science ®Google Scholar
• Shochat T, Cohen-Zion M, Tzischinsky O. Functional consequences of inadequate sleep in adolescents: a systematic review. Sleep Med Rev. 2014 Feb;18(1):75–87.
   PubMed Web of Science ®Google Scholar
• Chung KF, Yeung WF, Ho FY, et al. Predictors of daytime consequences of insomnia: the roles of quantitative criteria and nonrestorative sleep. Psychopathology. 2018;51(4):262–268.
   PubMed Web of Science ®Google Scholar
• Shekleton JA, Flynn-Evans EE, Miller B, et al. Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning. Sleep. 2014 Jan 1;37(1):107–116.
   PubMed Web of Science ®Google Scholar
• Soehner AM, Kaplan KA, Harvey AG. Prevalence and clinical correlates of co-occurring insomnia and hypersomnia symptoms in depression. J Affect Disord. 2014;167:93–97.
   PubMed Web of Science ®Google Scholar
• Seow LS, Subramaniam M, Abdin E, et al. Sleep disturbance among people with major depressive disorders (MDD) in Singapore. J Ment Health. 2016 Dec;25(6):492–499.
   PubMed Web of Science ®Google Scholar
• Sivertsen B, Vedaa Ø, Harvey AG, et al. Sleep patterns and insomnia in young adults: a national survey of Norwegian university students. J Sleep Res. 2018 Dec;4:e12790.
   Google Scholar
• Pigeon WR, Bishop TM, Krueger KM. Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings. Curr Psychiatry Rep. 2017 Aug;19(8):44.
   PubMed Web of Science ®Google Scholar
• Geoffroy PA, Hoertel N, Etain B, et al. Insomnia and hypersomnia in major depressive episode: prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study. J Affect Disord. 2018 Jan;15(226):132–141.
   Google Scholar
• Rumble ME, White KH, Benca RM. Sleep disturbances in mood disorders. Psychiatr Clin North Am. 2015 Dec;38(4):743–759.
   PubMed Web of Science ®Google Scholar
• Tempaku P, Hirotsu C, Mazzotti D, et al. Long sleep duration, insomnia, and insomnia with short objective sleep duration are independently associated with short telomere length. J Clin Sleep Med. 2018 Nov 29;14:jc-18–00113.
   PubMed Web of Science ®Google Scholar
• Grigolon RB, Trevizol AP, Cerqueira RO, et al. Hypersomnia and bipolar disorder: a systematic review and proportion meta-analysis. J Affect Disord. 2019 Mar 1;246:659–666.
   PubMed Web of Science ®Google Scholar
• Sanyal C, Asbridge M, Kisely S, et al. The utilization of antidepressants and benzodiazepines among people with major depression in Canada. Can J Psychiatry. 2011 Nov;56(11):667–676.
   PubMed Web of Science ®Google Scholar
• Manthey L1, Lohbeck M, Giltay EJ, et al. Correlates of benzodiazepine dependence in the Netherlands study of depression and anxiety. Addiction. 2012 Dec;107(12):2173–2182.
   PubMed Web of Science ®Google Scholar
• Kurko TA, Saastamoinen LK, Tähkäpää S, et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry. 2015 Nov;30(8):1037–1047.
   PubMed Web of Science ®Google Scholar
• O’Brien EM, Chelminski I, Young D, et al. Severe insomnia is associated with more severe presentation and greater functional deficits in depression. J Psychiatr Res. 2011 Aug;45(8):1101–1105.
   PubMed Web of Science ®Google Scholar
• Xiao L, Feng L, Zhu XQ, et al. Comparison of residual depressive symptoms and functional impairment between fully and partially remitted patients with major depressive disorder: a multicenter study. Psychiatry Res. 2018 Mar;261:547–553.
   PubMed Web of Science ®Google Scholar
• Chokroverty S. Overview of normal sleep. In: Chokroverty S, editor. Sleep disorders. New York, NY: Springer; 2017. p. 5–21.
   Google Scholar
• Woody ML, Gibb BE. Integrating NIMH research domain criteria (RDoC) into depression research. Curr Opin Psychol. 2015 Aug;4:6–12.
   PubMed Web of Science ®Google Scholar
• Sakurai H, Suzuki T, Yoshimura K, et al. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology (Berl). 2017 Aug;234(16):2453–2461.
   PubMed Web of Science ®Google Scholar
• Suri R, Stowe ZN, Cohen LS, et al. Prospective longitudinal study of predictors of postpartum-onset depression in women with a history of major depressive disorder. J Clin Psychiatry. 2017 Sep/Oct;78(8):1110–1116.
   PubMed Web of Science ®Google Scholar
• Nunes ML, Bruni O. Insomnia in childhood and adolescence: clinical aspects, diagnosis, and therapeutic approach. J Pediatr. 2015 Nov-Dec;91(6 Suppl 1):S26–35.
   Google Scholar
• Gulia KK, Kumar VM. Sleep disorders in the elderly: a growing challenge. Psychogeriatrics. 2018;18(3):155–165.
   PubMed Web of Science ®Google Scholar
• Pan Z, Park C, Brietzke E, et al. Cognitive impairment in major depressive disorder. CNS Spectr. 2019 Feb;24(1):22–29.
   PubMed Web of Science ®Google Scholar
• Nishida M, Nakashima Y, Nishikawa T. Slow sleep spindle and procedural memory consolidation in patients with major depressive disorder. Nat Sci Sleep. 2016 Jan;28(8):63–72.
   Google Scholar
• McKinnon AC, Hickie IB, Scott J, et al. Current sleep disturbance in older people with a lifetime history of depression is associated with increased connectivity in the default mode network. J Affect Disord. 2018 Mar;15(229):85–94.
   Google Scholar
• Fang X1, Zhang C2, Wu Z1, et al. The association between somatic symptoms and suicidal ideation in Chinese first-episode major depressive disorder. J Affect Disord. 2018 Oct;17(245):17–21.
   Google Scholar
• Don RJ, King L, St CK, et al. Depression and the relationship between sleep disturbances, nightmares, and suicidal ideation in treatment-seeking Canadian armed forces members and veterans. BMC Psychiatry. 2018 Jun 19;18(1):204.
   PubMedGoogle Scholar
• Eikelenboom M, Beekman ATF, Penninx BWJH, et al. A 6 year longitudinal study of predictors for suicide attempts in major depressive disorder. Psychol Med. 2018.
   Web of Science ®Google Scholar
• Michaels MS, Balthrop T, Nadorff MR, et al. Total sleep time as a predictor of suicidal behaviour. J Sleep Res. 2017 Dec;26(6):732–738.
   PubMed Web of Science ®Google Scholar
• Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996 Mar 15;39(6):411–418.
   PubMed Web of Science ®Google Scholar
• Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry. 1990 Jan;147(1):14–21.
   PubMed Web of Science ®Google Scholar
• Boland EM, Rao H, Dinges DF, et al. Meta-analysis of the antidepressant effects of acute sleep deprivation. J Clin Psychiatry. 2017 Sep/Oct;78(8):e1020–e1034.
   PubMed Web of Science ®Google Scholar
• Bunney BG, Li JZ, Walsh DM, et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry. 2015 Feb;20(1):48–55.
   PubMed Web of Science ®Google Scholar
• Charrier A, Olliac B, Roubertoux P, et al. Clock genes and altered sleep-wake rhythms: their role in the development of psychiatric disorders. Int J Mol Sci. 2017 Apr 29;18(5):E938.
   PubMed Web of Science ®Google Scholar
• Orozco-Solis R, Montellier E, Aguilar-Arnal L, et al. A circadian genomic signature common to ketamine and sleep deprivation in the anterior cingulate cortex. Biol Psychiatry. 2017 Sep 1;82(5):351–360.
   PubMed Web of Science ®Google Scholar
• Sun X, Zheng B, Lv J, et al., China Kadoorie Biobank (CKB) Collaborative Group. Sleep behavior and depression: findings from the China Kadoorie biobank of 0.5 million Chinese adults. J Affect Disord. 2018 Mar; 15(229):120–124.
   Google Scholar
• Lang CJ, Appleton SL, Vakulin A, et al. Co-morbid OSA and insomnia increases depression prevalence and severity in men. Respirology. 2017 Oct;22(7):1407–1415.
   PubMed Web of Science ®Google Scholar
• Stubbs B, Vancampfort D, Veronese N, et al. The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis. J Affect Disord. 2016 Jun;197:259–267.
   PubMed Web of Science ®Google Scholar
• Chen YH, Keller JK, Kang JH, et al. Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med. 2013 May 15;9(5):417–423.
   PubMed Web of Science ®Google Scholar
• Lichstein KL, Justin Thomas S, Woosley JA, et al. Co-occurring insomnia and obstructive sleep apnea. Sleep Med. 2013 Sep;14(9):824–829.
   PubMed Web of Science ®Google Scholar
• Bishop TM, Ashrafioun L, Pigeon WR. The association between sleep apnea and suicidal thought and behavior: an analysis of national survey data. J Clin Psychiatry. 2018 Jan/Feb;79(1):pii: 17m11480.
   PubMed Web of Science ®Google Scholar
• Hobzova M, Prasko J, Vanek J, et al. Depression and obstructive sleep apnea. Neuro Endocrinol Lett. 2017 Oct;38(5):343–352.
   PubMed Web of Science ®Google Scholar
• Chung F, Abdullah HR, Liao P. STOP-bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016 Mar;149(3):631–638.
   PubMed Web of Science ®Google Scholar
• Nagappa M, Liao P, Wong J, et al. Validation of the STOP-bang questionnaire as a screening tool for obstructive sleep apnea among different populations: a systematic review and meta-analysis. PLoS One. 2015 Dec 14;10(12):e0143697.
   PubMed Web of Science ®Google Scholar
• Venkateshiah SB, Ioachimescu OC. Restless legs syndrome. Crit Care Clin. 2015 Jul;31(3):459–472.
   PubMed Web of Science ®Google Scholar
• Koo BB, Blackwell T, Lee HB, et al., Osteoporotic Fractures in Men (MrOS) Study Group. Restless legs syndrome and depression: effect mediation by disturbed sleep and periodic limb movements. Am J Geriatr Psychiatry. 2016 Nov; 24(11):1105–1116.
   PubMed Web of Science ®Google Scholar
• Sarberg M, Bladh M, Svanborg E, et al. Postpartum depressive symptoms and its association to daytime sleepiness and restless legs during pregnancy. BMC Pregnancy Childbirth. 2016 Jun 6;16(1):137.
   PubMedGoogle Scholar
• Auvinen P, Mäntyselkä P, Koponen H, et al. Prevalence of restless legs symptoms according to depressive symptoms and depression type: a cross-sectional study. Nord J Psychiatry. 2018a Jan;72(1):51–56.
   PubMed Web of Science ®Google Scholar
• Auvinen P, Mäntyselkä P, Koponen H, et al. Elevation of tumor necrosis factor alpha levels is associated with restless legs symptoms in clinically depressed patients. J Psychosom Res. 2018b Dec;115:1–5.
   PubMed Web of Science ®Google Scholar
• Becker PM, Sharon D. Mood disorders in restless legs syndrome (Willis-Ekbom disease). J Clin Psychiatry. 2014 Jul;75(7):e679–94.
   PubMed Web of Science ®Google Scholar
• Soares CN, Murray BJ. Sleep disorders in women: clinical evidence and treatment strategies. Psychiatr Clin North Am. 2006;29(4):1095–1113.
   PubMed Web of Science ®Google Scholar
• Joffe H, Soares CN, Thurston RC, et al. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause. 2009;16(4):671–679.
   PubMed Web of Science ®Google Scholar
• Soares CN, Joffe H, Rubens R, et al. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol. 2006;108(6):1402–1410.
   PubMed Web of Science ®Google Scholar
• Joffe H, Crawford SL, Freeman MP, et al. Independent contributions of nocturnal hot flashes and sleep disturbance to depression in estrogen-deprived women. J Clin Endocrinol Metab. 2016;101(10):3847–3855.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Han KT, Jang SY, et al. The association between migraine and types of sleep disorder. Int J Environ Res Public Health. 2018 Nov 26;15:12.
   Web of Science ®Google Scholar
• Buse DC, Rains JC, Pavlovic JM, et al. Sleep disorders among people with migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2019 Jan;59(1):32–45.
   PubMed Web of Science ®Google Scholar
• Almoznino G, Haviv Y, Sharav Y, et al. An update of management of insomnia in patients with chronic orofacial pain. Oral Dis. 2017 Nov;23(8):1043–1051.
   PubMed Web of Science ®Google Scholar
• Generaal E, Vogelzangs N, Penninx BW, et al. Insomnia, sleep duration, depressive symptoms, and the onset of chronic multisite musculoskeletal pain. Sleep. 2017. 1. 40(1):Jan.
   Web of Science ®Google Scholar
• Frange C, Hachul H, Hirotsu C, et al. Temporal analysis of chronic musculoskeletal pain and sleep in postmenopausal women. J Clin Sleep Med. 2019 Feb 15;15(2):223–234.
   PubMed Web of Science ®Google Scholar
• Alföldi P, Dragioti E, Wiklund T, et al. Spreading of pain and insomnia in patients with chronic pain: results from a national quality registry (SQRP). J Rehabil Med. 2017 Jan 19;49(1):63–70.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Zhan Y, Zhang F, et al. Self-reported insomnia and coronary heart disease in the elderly. Clin Exp Hypertens. 2016;38(1):51–55.
   PubMed Web of Science ®Google Scholar
• Tan X, van Egmond L, Chapman CD, et al. Aiding sleep in type 2 diabetes: therapeutic considerations. Lancet Diabetes Endocrinol. 2018 Jan;6(1):60–68.
   PubMed Web of Science ®Google Scholar
• Sen A, Opdahl S, Strand LB, et al. Insomnia and the risk of breast cancer: the HUNT study. Psychosom Med. 2017 May;79(4):461–468.
   PubMed Web of Science ®Google Scholar
• Shi L, Wang J, Xu S, et al. Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials. Drug Des Devel Ther. 2016 Nov 25;10:3899–3907.
   PubMed Web of Science ®Google Scholar
• Fabbri C, Marsano A, Balestri M, et al. Clinical features and drug induced side effects in early versus late antidepressant responders. J Psychiatr Res. 2013 Oct;47(10):1309–1318.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Suzuki T, Uchida H, et al. Coping strategies for antidepressant side effects: an internet survey. J Affect Disord. 2012 Dec 20;143(1–3):89–94.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu X, Dong M, et al. Treatment of insomnia with tricyclic antidepressants: a meta-analysis of polysomnographic randomized controlled trials. Sleep Med. 2017 Jun;34:126–133.
   PubMed Web of Science ®Google Scholar
• Uher R, Farmer A, Henigsberg N, et al. Adverse reactions to antidepressants. Br J Psychiatry. 2009 Sep;195(3):202–210.
   PubMed Web of Science ®Google Scholar
• Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry. 1999 Oct;60(10):668–676.
   PubMed Web of Science ®Google Scholar
• Wichniak A, Wierzbicka A, Walęcka M, et al. Effects of antidepressants on sleep. Curr Psychiatry Rep. 2017 Aug 9;19(9):63.
   PubMed Web of Science ®Google Scholar
• Wichniak A, Wierzbicka A, Jernajczyk W. Sleep as a biomarker for depression. Int Rev Psychiatry. 2013 Oct;25(5):632–645.
   PubMed Web of Science ®Google Scholar
• Delaplace R, Garny de La Rivière S, Bon Saint Come M, et al. Sleep and disruptive mood dysregulation disorder: A pilot actigraphy study. Arch Pediatr. 2018 Jun 14;25:S0929-693X(18)30109-X.
   Web of Science ®Google Scholar
• Averill IR, Crowe M, Frampton CM, et al. Clinical response to treatment in inpatients with depression correlates with changes in activity levels and psychomotor speed. Aust N Z J Psychiatry. 2018 Jul;52(7):652–659.
   PubMed Web of Science ®Google Scholar
• van Diermen L, Schrijvers D, Cools O, et al. Distinguishing subgroups based on psychomotor functioning among patients with major depressive disorder. Neuropsychobiology. 2017;76(4):199–208.
   PubMed Web of Science ®Google Scholar
• DiNapoli EA, Gebara MA, Kho T, et al. Subjective-objective sleep discrepancy in older adults with MCI and subsyndromal depression. Geriatr Psychiatry Neurol. 2017 Nov;30(6):316–323.
   PubMed Web of Science ®Google Scholar
• Krane-Gartiser K, Vaaler AE, Fasmer OB, et al. Variability of activity patterns across mood disorders and time of day. BMC Psychiatry. 2017 Dec 19;17(1):404.
   PubMedGoogle Scholar
• Bernert RA, Luckenbaugh DA, Duncan WC, et al. Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depression. J Affect Disord. 2017 Jan 15;208:309–315.
   PubMed Web of Science ®Google Scholar
• Bourla A, Ferreri F, Ogorzelec L, et al. Assessment of mood disorders by passive data gathering: the concept of digital phenotype versus psychiatrist’s professional culture. Encephale. 2018 Apr;44(2):168–175.
   PubMed Web of Science ®Google Scholar
• Lorenz CP1, Williams AJ. Sleep apps: what role do they play in clinical medicine? Curr Opin Pulm Med. 2017 Nov;23(6):512–516.
   PubMed Web of Science ®Google Scholar
• Paré G, Leaver C, Bourget C. Diffusion of the digital health self-tracking movement in Canada: results of a national survey. J Med Internet Res. 2018 May 2;20(5):e177.
   PubMed Web of Science ®Google Scholar
• Sung SC, Wisniewski SR, Luther JF, et al., COMED Study Team. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report. J Affect Disord. 2015 Mar; 15(174):157–164.
   Google Scholar
• Srinivasan V, Brzezinski A, Pandi-Perumal SR, et al. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):913–923.
   PubMed Web of Science ®Google Scholar
• Urade CS, Mahakalkar SM, Tiple PG. A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study. J Pharmacol Pharmacother. 2015 Oct–Dec;6(4):198–203.
   PubMed Web of Science ®Google Scholar
• Alberti S, Chiesa A, Andrisano C, et al. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol. 2015 Jun;35(3):296–303.
   PubMed Web of Science ®Google Scholar
• Burrows GD, Kremer CM. Mirtazapine: clinical advantages in the treatment of depression. J Clin Psychopharmacol. 1997;17:34S–39S.
   PubMed Web of Science ®Google Scholar
• Karsten J, Hagenauw LA, Kamphuis J, et al. Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, cross-over, placebo-controlled trial. J Psychopharmacol. 2017 Mar;31(3):327–337.
   PubMed Web of Science ®Google Scholar
• Rothschild-Fuentes B, Roche A, Jiménez-Genchi A, et al. Effects of mirtazapine on the sleep wake rhythm of geriatric patients with major depression: an exploratory study with actigraphy. Pharmacopsychiatry. 2013 Mar;46(2):59–62.
   PubMed Web of Science ®Google Scholar
• Shen J, Moller HJ, Wang X, et al. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. J Clin Psychiatry. 2009 Mar;70(3):370–377.
   PubMed Web of Science ®Google Scholar
• Bertisch SM, Herzig SJ, Winkelman JW, et al. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014;37:343–349.
   PubMed Web of Science ®Google Scholar
• Liguori C, Ferini-Strambi L, Izzi F, et al. Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis. Br J Clin Pharmacol. 2019 Jan;85(1):240–244.
   PubMed Web of Science ®Google Scholar
• Krystal AD, Mittoux A, Meisels P, et al. Effects of adjunctive brexpiprazole on sleep disturbances in patients with major depressive disorder: an open-label, flexible-dose, exploratory study. Prim Care Companion CNS Disord. 2016 Sep 8;18(5).
   PubMedGoogle Scholar
• Peyron C, Kilduff TS. Mapping the hypocretin/orexin neuronal system: an unexpectedly productive journey. J Neurosci. 2017 Mar 1;37(9):2268–2272.
   PubMed Web of Science ®Google Scholar
• Mieda M. The roles of orexins in sleep/wake regulation. Neurosci Res. 2017 May;118:56–65.
   PubMed Web of Science ®Google Scholar
• Schwartz MD, Kilduff TS. The neurobiology of sleep and wakefulness. Psychiatr Clin North Am. 2015 Dec;38(4):615–644.
   PubMed Web of Science ®Google Scholar
• Coleman PJ, Gotter AL, Herring WJ, et al. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annu Rev Pharmacol Toxicol. 2017 Jan;6(57):509–533.
   Google Scholar
• Winrow CJ, Renger JJ. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br J Pharmacol. 2014 Jan;171(2):283–293.
   PubMed Web of Science ®Google Scholar
• Nollet M, Leman S. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention. CNS Drugs. 2013 Jun;27(6):411–422.
   PubMed Web of Science ®Google Scholar
• Murillo-Rodriguez E, Poot-Ake A, Arias-Carrion O, et al. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. Cent Nerv Syst Agents Med Chem. 2011 Sep 1;11(3):189–196.
   PubMedGoogle Scholar
• Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017 Apr;19(4):23.
   PubMed Web of Science ®Google Scholar
• Hsiao YT, Yi PL, Li CL, et al. Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. Neuropharmacology. 2012 Jan;62(1):373–384.
   PubMed Web of Science ®Google Scholar
• Irwin MR, Piber D. Insomnia and inflammation: a two hit model of depression risk and prevention. World Psychiatry. 2018 Oct;17(3):359–361.
   PubMed Web of Science ®Google Scholar
• Shariq AS, Brietzke E, Rosenblat JD, et al. Targeting cytokines in reduction of depressive symptoms: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Apr;20(83):86–91.
   Google Scholar
• Maes M, Noto C, Brietzke E. Omics-based depression and inflammation research. Braz J Psychiatry. 2015;37(1):1–2. Jan–Mar.
   PubMedGoogle Scholar
• Noto C, Rizzo LB, Mansur RB, et al. Targeting the inflammatory pathway as a therapeutic tool for major depression. Neuroimmunomodulation. 2014;21(2–3):131–139.
   PubMed Web of Science ®Google Scholar